0001209191-19-029005.txt : 20190510
0001209191-19-029005.hdr.sgml : 20190510
20190510170108
ACCESSION NUMBER: 0001209191-19-029005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190508
FILED AS OF DATE: 20190510
DATE AS OF CHANGE: 20190510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLARKE JOHN K
CENTRAL INDEX KEY: 0001219015
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 19815810
MAIL ADDRESS:
STREET 1: C/O CARDINAL HEALTH PARTNERS
STREET 2: 221 NASSAU STREET
CITY: PRINCETON
STATE: NJ
ZIP: 08542
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-731-8389
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-08
0
0001339970
aTYR PHARMA INC
LIFE
0001219015
CLARKE JOHN K
3545 JOHN HOPKINS COURT, SUITE #250
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (right to buy)
0.5834
2019-05-08
4
A
0
20000
0.00
A
2029-05-08
Common Stock
20000
20000
D
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 8, 2020 or (ii) the Issuer's 2020 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
Nancy Krueger, as Attorney-in-Fact
2019-05-10